Summary:
Seeking individuals with a diagnosis of Stage 2, 3 or 4 COPD, Idiopathic Pulmonary Fibrosis or a cardiac rhythm disorder: Atrial Fibrilation, Bi/Tri/Quadrigeminy, Bradycardia or PVCs/PACs to participate in a study that takes approximately 5 hours to complete while collecting data using devices.
There is no investigational medication used for this study. Those with COPD may be eligible to continue the study for a portion that collects data while the participant carries on their daily activities. The take home portion lasts for up to 14 days.
Requirements (at the time of screening):
- Diagnosed with Stage 2, 3 or 4 COPD, Idiopathic Pulmonary Fibrosis OR
- Cardiac arrhythmia noted on ECG during the screening visit
- COPD participants must provide a Pulmonary Function Test (PFT) result taken within the last 5 years
- Must have and be able to use all fingers (excluding thumbs)
- No hand tremors
- Must be able to provide documentation of full vaccination status for COVID
- Pacemaker or AICD are exclusion criteria
Qualified Participants May Receive:
Up to $425 for the in-clinic portion of the study, and up to $2,000 for the at-home portion of the study - COPD subjects only.